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Malaria liver stage infection is an obligatory parasite development step and represents 
a population bottleneck in Plasmodium infections, providing an advantageous target for 
blocking parasite cycle progression. Parasite development inside hepatocytes implies a 
gross cellular insult evoking innate host responses to counteract intra-hepatocytic infec-
tion. Using primary hepatocyte cultures, we investigated the role of Kupffer cell-derived 
hepatocyte growth factor (HGF) in malaria liver stage infection. We found that Kupffer cells 
from Plasmodium-infected livers produced high levels of HGF, which trigger apoptosis 
of infected hepatocytes through a mitochondrial-independent apoptosis pathway. HGF 
action in infected hepatocyte primary cultures results in a potent reduction of parasite 
yield by specifically sensitizing hepatocytes carrying established parasite exo-erythro-
cytic forms to undergo apoptosis. This apoptosis mechanism is distinct from cell death 
that is spontaneously induced in infected cultures and is governed by Fas signaling mod-
ulation through a mitochondrial-dependent apoptosis pathway. This work indicates that 
HGF and Fas signaling pathways are part of an orchestrated host apoptosis response 
that occurs during malaria liver stage infection, decreasing the success of infection of 
individual hepatocytes. Our results raise the hypothesis that paracrine signals derived 
from Kupffer cell activation are implicated in directing death of hepatocytes infected with 
the malaria parasite.
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inTrODUcTiOn
Malaria remains a major global health problem. It is estimated that 3.2 billion people are at risk of 
developing the disease (1), which represents a serious socioeconomic burden in malaria endemic 
countries (2). The natural infection is initiated by Plasmodium sporozoites that reach the liver and 
infect hepatocytes—the preferred site of parasite replication and an obligatory step for cycle progres-
sion in the mammalian host (3). Through a high-efficacy process of pre-erythrocytic schizogony, 
one sporozoite develops into a liver stage form that undergoes exponential growth entrenching 
thousands of merozoites inside the parasitophorous vacuole in each infected hepatocyte (4). Parasite 
Abbreviations: HGF, hepatocyte growth factor; KC, Kupffer cell; EEFs, exo-erythrocytic forms; TREM2, triggering receptor 
expressed in myeloid cells 2; NKT, natural killer T; ACK, ammonium chloride potassium; TUNEL, terminal deoxynucleotidyl 
transferase dUTP nick end labeling; Ct, cycle threshold; DAPI, 4′,6-diamidino-2-phenylindole; NPCs, liver non-parenchymal 
cells; lpr, lymphoproliferation; FasL, Fas ligand.
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invasion and the expansion of exo-erythrocytic forms (EEFs) 
inside hepatocytes represent a prominent cellular insult that 
plausibly elicits host strategies to counteract EEFs development.
Malaria liver stage infection has shown to induce local innate 
immune responses. Plasmodium infection has been shown to 
trigger a type I interferon response that mediates an inflamma-
tory reaction in the liver (5, 6). Plasmodium RNA was shown to 
work as a ligand of the cytosolic pattern recognition receptor 
Mda5, which activates a type I IFN response via the adaptor 
molecule Mavs and the transcription factors Irf3 and Irf7 (6). 
This response decreases liver parasite load possibly because 
type I IFN signaling in myeloid cells contributes to the recruit-
ment of immune cells to the inflammatory foci around infected 
hepatocytes (6). In fact, recruitment of natural killer T (NKT) 
cells in sporozoites-infected livers was shown to be dependent 
on the expression of interferon-alpha/beta receptor alpha chain 
(5). Another line of evidence indicates that activation of Kupffer 
cells is a key component in the outcome of malaria liver stage 
infection. We have shown that pro-inflammatory activation of 
Kupffer cells by sporozoites is critically regulated by the innate 
immunity receptor triggering receptor expressed in myeloid 
cells 2 (TREM2). The level of TREM2 expression in Kupffer cells 
directly correlates with natural resistance liver stage infection 
and with reduced hepatocyte parasite yield (7). Nevertheless, the 
molecular mechanisms by which Kupffer cells control hepatocyte 
infection are not completely unveiled.
The outcome of liver stage infection results from balancing 
host defense responses and parasite mechanisms that counteract 
such responses. In particular, the success of parasite development 
and growth inside individual hepatocytes is dependent on the 
ability to sustain host cell survival until late stages of infection 
(8). In fact, it has been shown that parasite survival depends on 
inhibition of hepatocyte apoptosis mechanisms, including p53 
downregulation and inhibition of mitochondrial-dependent 
induced cell death (9, 10).
Once sporozoites cross the hepatic sinusoidal barrier, they 
traverse several hepatocytes before invading and establishing 
an intracellular infection (11). Shifting to the invasive mode 
requires the action of host factors released during hepatocyte 
traversing (12). Hepatocyte growth factor (HGF) signaling has 
been shown to facilitate Plasmodium berghei sporozoite infec-
tion in hepatoma cells (13), possibly by conferring resistance to 
induced cell death (14). Nevertheless, experimental infection of 
different hepatoma cell lines showed that the induction of HGF 
signaling did not improve Plasmodium falciparum invasion (15) 
and was not crucial for infection by P. falciparum or Plasmodium 
yoelii (16).
We tested the hypothesis that the local innate immune 
response induced by P. berghei liver stage infection was involved 
in triggering apoptosis of infected hepatocytes. In particular, 
we investigated whether HGF signaling pathway is involved in 
apoptosis of infected hepatocytes and takes part in the response 
of liver innate immune cells to malaria infection. Our results indi-
cate that activation of Kupffer cells by malaria parasites entails the 
production of HGF that specifically induce apoptosis of infected 
hepatocytes. This work supports the view that HGF plays multiple 
roles during malaria liver stage infection.
MaTerials anD MeThODs
Mice
All procedures involving laboratory mice were in accordance 
with national (Portaria 1005/92) and European regulations 
(European Directive 86/609/CEE) on animal experimentation 
and were approved by the Instituto Gulbenkian de Ciência Ethics 
Committee, and the Direcção-Geral de Veterinária (the Official 
National Entity for regulation of laboratory animals usage). The 
mice were bred and maintained in conventional housing facili-
ties at the Instituto Gulbenkian de Ciência. All experiments were 
conducted using male mice with 8–15 weeks of age from strains 
C57BL/6, BALB/c, and B6. lpr (B6.MRL-Faslpr/J).
hepatocyte Primary cultures
Mouse primary hepatocytes were prepared as previously 
described (17). In short, mouse liver lobes were perfused with liver 
perfusion medium and liver digest medium (Gibco; Invitrogen) 
at 37°C. Dissociated cells from the tissue were separated using 
a 1.12, 1.08, and 1.06  g/ml Percoll (GE Healthcare) gradient. 
Hepatocytes were collected from the gradient solution and 
cultured in William’s E complete medium (Gibco; Invitrogen) in 
plates or glass coverslips coated with 0.2% gelatine. The viability 
of hepatocytes in each experiment preparation was assessed by 
vital staining with Trypan blue and by cell morphology in FACS 
analysis. All the experiments were performed with viability of 
hepatocytes preparations  above 80% purity. The remaining dead 
cells were removed 12 h post-plating (12 h prior infection), as in 
freshly isolated preparations dead hepatocytes do not attach. HGF 
conditioning was performed by adding 100 ng/ml of recombinant 
mouse HGF (eBioscience) 1 h prior infection, with a subsequent 
wash before infection.
Parasites and infection
Green fluorescent protein (gfp)-expressing P. berghei ANKA 
(Pb) (18), P. yoelii 17XNL (Py), and Pb-spect(-)1 (19) sporozoites 
were obtained after dissection of infected salivary glands from 
Anopheles stephensi mosquitoes bred in the insectarium of the 
Instituto de Medicina Molecular, Lisbon. Briefly, mosquitoes were 
immobilized, and the thorax and abdomen were separated with 
fine forceps. The salivary glands were dissected from the thoraces 
into RPMI medium, collected to a 1.5 ml Eppendorf, and smashed 
to release the sporozoites. The sporozoites were collected from the 
supernatant upon a 2 min × 5 min 800 rpm centrifugation (20). 
The same procedure was applied to non-infected mosquitoes 
to obtain salivary glands suspensions. Mice were intravenously 
inoculated with 104 sporozoites each. Hepatocytes were infected 
with 1.5 to 3.5 × 104 sporozoites, and non-infected controls were 
mock infected with salivary glands suspensions of non-infected 
mosquitoes.
isolation of liver non-Parenchymal  
cells (nPcs)
Non-parenchymal cells were isolated from mouse livers at 
40 h post-infection. Cells were obtained by adapting a method 
previously described (21). Briefly, liver lobes were removed 
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and perfused with liver perfusion medium (Gibco; Invitrogen) 
with 750 mg/l of Collagenase H (Roche) at 37°C. The resulting 
suspension was filtered through a 100  µm cell strainer (BD 
Falcon). The dissociated cells were suspended in liver perfusion 
medium and centrifuged for 10 min at 1,500 rpm, resuspended 
in RPMI complete medium (Gibco; Invitrogen), mixed in 
Percoll (GE Healthcare) solution to give a final concentration 
of 30% Percoll, and then centrifuged at 2,000 rpm for 10 min. 
The cell pellet was resuspended in RPMI and carefully laid on 
30% Percoll solution and centrifuged at 2,000 rpm for 10 min. 
The cell pellet collected was washed and resuspended in ACK 
(NH4Cl 0.15  M, KHCO3 10  mM, Na2EDTA⋅2H2O 0.1  mM 
and pH 7.2) for 3  min to lyse remaining erythrocytes. Cells 
were washed and centrifuged at 800  rpm for 20  s to discard 
the remaining hepatocytes; the supernatant was recovered, and 
NPCs were collected at 1,500 rpm for 5 min.
Total rna and cDna synthesis
Livers and NPCs were collected at 40  h post-infection, imme-
diately homogenized in denaturing solution and total RNA was 
obtained using High Pure RNA Tissue Kit and High Pure RNA 
Kit (Roche). One microgram of total RNA was converted to 
cDNA (Transcriptor First Strand cDNA Synthesis Kit; Roche). 
Hepatocytes in culture were collected at 24 h post-infection, the 
lysis and reverse transcriptase reaction were performed using 
TaqMan Gene Expression Cell-to-CT kit (Ambion).
Plasmodium rna Quantification  
and hepatocyte gene expression
cDNA specific to P. berghei 18S rRNA was amplified by 
using the Taqman specific primers: IGC-Pb1 (forward) 
5′-CCGATAACGAACGAGATCTTAACCT-3′, IGC-Pb2 (rev-
erse) 5′-CGTCAAAACCAATCTCCCAATAAAGG-3′ and IGC- 
Pb3 (specific fluorogenic probe) 5′-FAM–ACTCGCCGCTAAT 
TAG–MGB-3′ (7). cDNA specific to P. yoelii 18S rRNA was ampli-
fied by using the SYBR green system and the specific primers 
NYU-Py3 5′-GGGGATTGGTTTTGACGTTTTTGCG-3′ and 
NYU-Py5 5′-AAGCATTAAATAAA GCGAATACATCCTTAT-3′ 
(22). Hgf, Bid, Casp3, Hifα, Pik3r1, Cflar, Fadd, and Casp8 expres-
sion was quantified using TaqMan Gene Expression Assays from 
ABI (Mm01135185_m1, Mm00432073_m1, Mm01195084_m1, 
Mm00468872_m1, Mm01282780, Mm01255576_m1, Mm004-
38861_m1, and Mm00802247_m1, respectively). Endo genous 
control Gapdh (Mouse GAPD Endogenous Control; ABI) was 
used in multiplex PCR with target genes. PCR reactions were per-
formed with ABI Prism 7900HT, and relative quantification was 
calculated by the ΔΔCt method, using the mean of the control 
group as calibrator.
hepatocyte immunocytochemistry: 
TUnel, eeFs, and Fasl
Hepatocytes cultured on coverslips were fixed 24 or 40 h post-
infection with 4% paraformaldehyde (PFA) and incubated with 
50 nM NH4Cl to extinguish PFA activity. Cells were permeabi-
lized and blocked with blocking solution for 1 h [3% of Bovine 
Serum Albumin (Calbiochem), 100  mM of glycine, 0.1% of 
saponin, and 10% of Fetal Calf Serum (Gibco; Invitrogen) in 
PBS 1×] and stained for apoptosis by Terminal Deoxynucleotidyl 
Transferase dUTP Nick End Labeling (TUNEL) using “In  Situ 
Cell Death Detection—TMR” (Roche); to stain EEFs coverslips 
were then incubated 45 min at room temperature with blocking 
solution containing anti-GFP IgG Alexa-488 conjugated anti-
body (Invitrogen); followed by DAPI staining (Invitrogen) and 
mounted with MOWIOL (Calbiochem); to stain FasL, cells were 
incubated 45  min at room temperature with blocking solution 
containing anti-FasL (CD178.1 Kay10; BD Pharmingen) followed 
by DAPI staining (Invitrogen) and mounted with MOWIOL 
(Calbiochem). Cell culture images were acquired using an 
automated Nikon Eclipse TE2000-S inverted fluorescence 
microscope, with a 20× objective, covering the total coverslip 
area. ImageJ (NIH) software was used to differentially identify 
TUNEL-positive or -negative (live) cells, EEFs and FasL in each 
coverslip, and to estimate single EEFs area. Results are expressed 
as the number of TUNEL-positive cells and live cells with EEFs 
per 100 microscopic fields, or FasL+ cells per 103 cells.
Kupffer cells Facs analysis  
and Purification
Liver macrophages were stained, at 4°C, by incubating liver 
NPCs with F4/80 APC (A3-1; Serotec), CD11c PE (HL3; BD 
Pharmingen), and CD49b Biotin (DX5 and streptavidin-PerCP; 
BD Pharmigen) antibodies. Subsequently, a two-step HGF 
intracellular staining (H170; Santa Cruz and goat anti-rabbit 
IgG-FITC) was performed by using the BD Cytofix/Cytoperm 
kit. FACScalibur cytofluorometer (Becton Dickinson) and FlowJo 
software were used for FACS analysis. Purified Kupffer cells were 
obtained through high-speed cell sorting (FACSAria; Becton 
Dickinson), after staining with F4/80 APC (Serotec).
Kupffer cell–hepatocyte  
Transwell cultures
We used a 0.4-µm transwell culture system (Millipore) to allow 
purified Kupffer cells (upper chamber) to exchange soluble factors 
during 12 h with primary hepatocyte cultures (lower chamber), 
before infection. Hepatocytes were then infected with P. berghei 
ANKA sporozoites and fixed for parasite and apoptosis staining 
or collected for RNA analysis at 24 h post-infection. For HGF/
MET signaling blocking, we added anti-Met antibodies (N-17; 
Santa Cruz Biotechnology) at 400 ng/ml when purified Kupffer 
cells were put in culture with primary hepatocytes followed by an 
additional 400 ng/ml added 1 h prior infection.
hgF elisa
Hepatocyte growth factor secretion in the supernatants from 
transwell cultures was evaluated by sandwich ELISA. Briefly, 
maxisorp plates were coated with a capture anti-HGF antibody 
(H-170;, Santa Cruz) in 0.5 M Carbonate Bicarbonate Solution. 
Detection used anti-HGF-biotinylated antibody (BAF2207; 
R&D). Samples were quantified against a standard curve with 
mouse recombinant HGF (eBioscience).
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Fas Pathway Modulation
Fas-blocking experiments were performed by using either a 
blocking antibody or a pan-caspase inhibitor. We used 10  µg/
ml of anti-FasL antibody (CD178.1 Kay10; BD Biosciences) and 
20  µM of Z-VAD-FMK (pan-caspase inhibitor – 550377; BD 
Biosciences), added 1 h prior infection and using the appropri-
ate controls. Fas signaling was induced with 1 µg/ml of anti-Fas 
antibody (CD95 Jo2; BD Biosciences) 18 h post-infection with 
P. berghei. Cflar knockdown was achieved through a mixture of 
three distinct siRNAs (s63907, s63908, and s63909; Ambion), at a 
concentration of 20 µM that was delivered to primary hepatocytes 
with Oligofectamine (Invitrogen). Control samples included 
untransfected cells and cells transfected with a negative control 
siRNA (Ambion) or with a positive control targeting mouse 
Gapdh (Ambion).
statistical analysis
All experiments were performed with a minimum of triplicate 
samples, and data are representative of at least three independent 
experiments. Results are presented as average values and error 
bars represent SD. Statistical analysis used a Mann–Whitney test, 
and p < 0.05 was considered statistically significant.
resUlTs
hgF impacts on the Yield of Plasmodium 
liver stage infection
Liver NPCs, specifically Kupffer cells, have a role in the natural 
control of Plasmodium liver stage expansion (7). We found that 
Hgf mRNA expression in isolated non-parenchymal liver cells 
was highly increased upon in  vivo infection with P. berghei 
sporozoites (Figure 1A) and correlated with relative resistance to 
parasite liver stage expansion in BALB/c as compared to C57BL/6 
mice (Figure 1B). It has been reported that HGF and its mRNA 
localize exclusively to NPCs in the liver (23–25), and we have 
confirmed that expression of Hgf mRNA in primary hepatocytes 
was not detectable, irrespective to infection with P. berghei (data 
not shown). Given that HGF has been shown to facilitate liver 
stage infection (13, 14, 16), we investigated the cellular source 
of HGF in infected livers. FACS analysis of NPCs isolated from 
sporozoite-infected mice revealed that F4/80+ cells, represent-
ing Kupffer cells, expressed intracellular HGF as opposed to 
other NPCs, e.g., CD11c+ (dendritic cells) or CD49b+ cells that 
include NKT and NK cells (Figure 1C). Furthermore, we found 
that depletion of liver macrophages abrogated the augmented 
expression of HGF in the liver induced by infection (Figure S1 
in Supplementary Material) suggesting that liver macrophages 
are the main in vivo source of HGF in malaria liver stage infec-
tion. To untangle the effect of HGF in Plasmodium liver stage 
infection, we pre-treated hepatocyte primary cultures of C57BL/6 
and BALB/c mice with HGF 1  h prior infection and observed 
that HGF conditioning similarly impairs parasite yield in both 
mouse strains (Figure  1D). Moreover, HGF pre-treatment of 
C57BL/6 hepatocytes infected with P. yoelii (Figure  1E) or P. 
berghei-spect(-)1 (Figure 1F) revealed that reduction of parasite 
yield induced by HGF transcends Plasmodium species and is 
independent of hepatocyte traversing (19). In addition, we found 
that reduction of parasite burden by HGF was attributable to a 
significant decrease in the number of hepatocytes carrying EEFs 
(Figure  1G), detectable from 24  h post-infection onward. In 
contrast, HGF conditioning was not associated with altered EEFs 
size, neither at earlier stages (24 h) (Figure 1H) nor at the end of 
the liver infection (40 h) (Figure 1I). These results show that HGF 
conditioning reduces the number of hepatocytes that carry EEFs, 
rather than affecting its development suggesting that Kupffer 
cell-derived HGF impacts on the survival of infected hepatocytes.
hgF Promotes apoptosis of eeF-carrying 
hepatocytes
We investigated whether the reduced number of developed EEFs 
upon HGF pre-treatment was due to apoptosis of infected hepat-
ocytes. Analysis of mRNA expression of key informative genes 
showed that HGF induces downregulation of PI3K a component 
of the HGF/c-Met pathway that is involved in apoptosis protection 
(26, 27) (Figure 2A). Moreover, HGF downregulated Hif1-alpha 
that has been associated with hepatocyte apoptosis and efficiency 
of P. berghei infection (28, 29) (Figure 2B). Furthermore, upregu-
lation of Caspase 3 (Figure 2C), with a concomitant decrease of 
Bid expression (Figure  2D), suggests that HGF acts through a 
mitochondrial-independent apoptosis pathway in response to 
hepatocyte Plasmodium infection (30).
Interestingly, we observed that HGF pre-treatment specifically 
increased apoptosis susceptibility in parasitized hepatocytes 
but did not affect bulk apoptosis in the infected cultures 
(Figures  2E,F), as detected by TUNEL assays. Remarkably, in 
HGF pre-treated cultures, the size distribution of EEFs inside 
apoptotic hepatocytes significantly deviated to higher values 
(p-value <0.0001) (Figure 2G). Thus, in untreated infected cul-
tures, hepatocytes carrying small EEFs were the major target of 
spontaneous apoptosis, but under HGF conditioning significant 
apoptosis was observed in infected hepatocytes with larger EEFs 
(Figures 2G,H). Collectively, these data indicate that parasitized 
primary hepatocytes respond to HGF treatment through a 
mitochondrial-independent apoptosis mechanism, which oper-
ates in hepatocytes carrying early liver schizont stages that are 
refractory to spontaneous apoptosis.
Kupffer cell-Derived hgF and efficiency  
of Primary hepatocyte infection
We ask whether HGF secreted by Kupffer cells could impair 
hepatocyte infection in vitro. We performed transwell co-culture 
experiments using FACS sorted F4/80+ cells from infected liv-
ers and naïve primary hepatocytes. Remarkably, we observed 
that parasite yield and the number of infected hepatocytes were 
reduced in the presence of Kupffer cells, to an extent comparable 
to the cultures pre-treated with HGF (Figures 3A,B), indicating 
that this effect is attributable to soluble factors derived from 
Kupffer cells. Moreover, HGF was detected in the supernatants of 
Kupffer cells/hepatocyte cultures (Figure 3C), which were able 
to reduce parasite yield when used as media in pure hepatocyte 
cultures (Figure 3D). Furthermore, adding anti-MET antibodies 
in the co-cultures to block the action of Kupffer cells-derived 
FigUre 1 | continued
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FigUre 2 | hepatocyte growth factor (hgF)-conditioning targets exo-erythrocytic form (eeF)-containing hepatocytes for mitochondrial-independent 
apoptosis. Effect of HGF on the mRNA expression of selected apoptosis-related markers Pik3r1 (a), Hif-α (B), Caspase 3 (c), and Bid (D) in infected (INF) and 
non-infected (non-INF) hepatocyte cultures at 24 h p.i. Results represent qRT-PCR estimates relative to non-infected untreated hepatocyte cultures. Effects of HGF 
pre-treatment on the viability of primary hepatocytes at 24 h p.i. with Plasmodium berghei sporozoites: (e) apoptotic cells containing EEFs, (F) total apoptotic cells 
(TUNEL; TUNEL-positive), and (g) size distribution of EEFs harbored in apoptotic cells. (h) Representative immunofluorescence images of primary hepatocyte 
cultures in the presence (right) or absence (left) of HGF pre-treatment, evidencing larger EEFs in TUNEL + cells after HGF pre-treatment (TUNEL-positive nuclei in 
red, DAPI-positive in blue and EEFs in green; scale bar 10 µm) (non-parametric Mann–Whitney test, *p < 0.05, **p ≤ 0.001, and ***p ≤ 0.0001). Data are 
represented as mean ± SD of triplicate cultures that were performed in at least three independent experiments.
FigUre 1 | continued 
hepatocyte growth factor (hgF) and yield of malaria liver stage infection in vivo and in vitro. Differential resistance to malaria liver stage infection in C57/
BL/6 and BALB/c mice correlates with increase of HGF expression in non-parenchymal cells (NPCs) (a,B): (a) Hgf mRNA quantification in liver NPCs preparations 
of infected and non-infected mice and (B) liver parasite burden measured by qRT-PCR of Plasmodium berghei 18S rRNA, measured at 40 h p.i. with P. berghei 
sporozoites. FACS analysis of liver NPCs isolated from C57BL/6-infected mice revealed high HGF intracellular expression in F4/80+ cells (c). HGF pre-treatment of 
hepatocyte primary cultures infected with P. berghei ANKA reduced malaria liver stage parasite yield in C57BL/6 and BALB/c hepatocytes (D) and in C57BL/6 
hepatocytes infected with Plasmodium yoelii (e) or Spect1 deficient P. berghei (F), at 24 h p.i. Effect of HGF pre-treatment in the counts of viable hepatocytes 
containing exo-erythrocytic forms (EEFs) (g) and EEFs size (h,i), at 24 and 40 h p.i. in C57BL/6 hepatocyte primary cultures (non-parametric Mann–Whitney test, 
*p < 0.05 and **p ≤ 0.001). Data are represented as mean ± SD of three livers per mouse strain or triplicate cultures that were performed in at least three 
independent experiments.
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HGF led to increased parasite yield in hepatocytes (Figure 3E). 
Altogether, these results strongly suggest that HGF is secreted by 
Kupffer cells and acts in an endocrine fashion to reduce successful 
progression of infection in parasitized hepatocytes.
involvement of Fas-Mediated apoptosis  
in Plasmodium liver stage infection
Additionally, it has been described that the failure of EEFs to 
attain full development in vitro is attributable to an hepatocyte 
autonomous mitochondrial-dependent apoptosis response (10). 
In line with these observations, we asked whether reduction of 
the number of EEFs in infected primary hepatocyte cultures 
occurs as well in the absence of HGF. To ascertain the success of P. 
berghei sporozoites infection in hepatocyte primary cultures, we 
performed time course counting of infected hepatocytes, which 
showed that less than 50% of the initial infected cells attained 
EEF full development (Figure  4A). To investigate whether the 
aborted EEFs were related to apoptosis induction in P. berghei-
infected cultures, we analyzed the expression of apoptosis genes 
FigUre 3 | Kupffer cells secrete hepatocyte growth factor (hgF) and control efficacy of primary hepatocyte infection. Transwell co-cultures of liver 
F4/80+ cells (upper chamber) and primary hepatocytes (lower chamber) were compared at 24 h p.i. (Kupffer), with single hepatocytes cultures pre-treated with HGF 
(HGF) or left untreated (CTR), for parasite yield (a) and number of viable hepatocytes containing exo-erythrocytic forms (EEFs) (B). Secreted HGF was evaluated in 
the supernatant of untreated hepatocytes and co-cultures after infection (c). Parasite yield in hepatocyte cultures treated with HGF or incubated with culture 
supernatant from previous single hepatocytes culture (Hep medium) or from previous hepatocyte-F4/80+ cells co-culture in transwell (Kupffer medium) (D). Parasite 
yield at 24 h p.i. in transwell co-cultures of liver F4/80+ cells and primary hepatocytes in the absence (Kupffer) or presence (Kupffer + αMET) of anti-MET blocking 
antibody (e) (non-parametric Mann–Whitney test, *p < 0.05 and **p ≤ 0.001). Data are represented as mean ± SD of triplicate cultures that were performed in at 
least three independent experiments, except (e) that represents cumulative data of two independent experiments with triplicate samples.
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in hepatocyte primary cultures and found out that Fas pathway 
signaling-related genes were significantly altered at 24  h p.i. A 
strong upregulation of Bid coupled with a slight upregulation of 
other proapoptotic genes and downregulation of the anti-apop-
totic Cflar, represent a signature that Fas pathway signaling was 
induced in infected primary cultures (Figure  4B), presumably 
executing a Type II apoptotic response that requires mitochon-
drial participation (31). To test whether Fas pathway signaling 
was detrimental to successful hepatocyte infection, we analyzed 
primary hepatocytes from lpr mice (Fas-null mutant), which 
demonstrated that at 24 h p.i. the parasite yield was significantly 
increased in the absence of Fas pathway signaling. An effect that 
was also observed by blocking Fas pathway signaling with anti-Fas 
Ligand antibodies or with a pan-Caspase inhibitor (Figure 4C). 
Furthermore, the absence of Fas pathway signaling improved 
the number of successfully infected hepatocytes (Figure  4D), 
possibly because apoptosis induced by infection was partially 
dependent on Fas pathway signaling (Figure 4E). Interestingly, 
immunofluorescence microscopy of infected cultures revealed 
prominent FasL expression in non-infected hepatocytes as 
compared to infected hepatocytes (Figure  4F), indicating that 
induction of FasL expression by P. berghei infection (Figure 4G) 
impacts the viability of both infected and non-infected hepato-
cytes. Conversely, enhancing Fas pathway signaling in hepato-
cytes either by adding anti-Fas antibodies or by knocking down 
Cflar, a potent Fas pathway inhibitor (32), increased apoptosis 
FigUre 4 | Fas-mediated hepatocyte apoptosis impairs the success of Plasmodium berghei infection (a) exo-erythrocytic form (eeF)-containing 
viable hepatocytes were counted at indicated times in infected primary cultures. (B) mRNA quantification of Fas pathway genes at 24 h p.i., relative to 
non-infected control (CTR) hepatocyte cultures. (c) Parasite yield in infected cultures of Fas-deficient hepatocytes from B6. lpr mice or after blocking Fas pathway 
with anti-FasL antibody was measured by qRT-PCR of P. berghei 18S rRNA at 40 h p.i. (D) EEF-containing viable hepatocytes of B6. lpr and C57BL/6 mice were 
counted and (e) the number of apoptotic cells was determined by TUNEL staining in infected and non-infected cultures at 24 h p.i. (F) Representative 
immunofluorescence image of non-infected hepatocyte expressing FasL (red) in the vicinity of P. berghei-gfp (green) infected hepatocytes [nuclei stained with DAPI 
(blue)], scale bar—20 µm and (g) counting of FasL-expressing cells in infected and non-infected cultures at 24 h p.i. (h,K) number of apoptotic cells (TUNEL-
positive), (i,l) number of viable hepatocytes containing EEFs, and (J,M) parasite yield were measured in primary hepatocyte cultures in the presence or absence of 
signaling by anti-Fas antibody and/or Cflar siRNA (non-parametric Mann–Whitney test, *p < 0.05, **p ≤ 0.001, and ***p ≤ 0.0001). Data are represented as 
mean ± SD of triplicate cultures that were performed in at least three independent experiments.
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susceptibility in infected hepatocyte cultures (Figures 4H,K). In 
these conditions, we observed decreased number of hepatocytes 
containing EEFs (Figures  4I,L) and reduced parasite yield 
(Figures 4J,M). The effects of Cflar knockdown were exacerbated 
by anti-Fas stimulation (Figures  4K–M) and strongly suggest 
that Cflar inhibition sensitized hepatocytes to undergo apoptosis 
through the Fas pathway. These experiments provide evidence 
that apoptosis signals evoked by the parasite favor Fas-dependent 
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hepatocyte apoptosis in infected cultures leading to a decrease 
in the number of infected primary hepatocytes that support full 
parasite development.
DiscUssiOn
This work revealed an unpredicted hepatocyte—Kupffer cell 
crosstalk mediated by HGF, which sensitizes Plasmodium-
infected hepatocytes to undergo apoptosis. Furthermore, we 
provide evidence that Fas-mediated hepatocyte apoptosis is 
spontaneously induced in infected cultures. Together, the results 
support the notion that hepatocyte response to Plasmodium 
in vitro infection entails two distinct apoptosis mechanisms: (1) 
an HGF-stimulated mitochondrial-independent response that 
preferably targets hepatocytes harboring early liver schizonts and 
(2) a Fas-mediated mitochondrial-dependent apoptosis mecha-
nism, acting on both infected and non-infected hepatocytes. 
Our results suggest that these two responses operate at distinct 
phases of hepatocyte infection and use different genetic programs 
for apoptosis induction, representing diverse modes to control 
malaria liver stage infection.
We have previously shown that expression of innate immunity 
receptors in Kupffer cells, namely, TREM2, is involved in the 
genetic resistance to malaria liver stage infection in mouse mod-
els (7). We now demonstrate an additional mechanism of parasite 
yield control mediated by Kupffer cells that specifically targets 
infected hepatocytes in culture. After in vivo infection, HGF is 
upregulated in the liver and is mainly expressed by Kupffer cells. 
This is in line with the notion that HGF and its mRNA localize 
exclusively to non-parenchymal liver cells (23), namely, Kupffer 
cells (24). Furthermore, increased HGF mRNA expression in 
the liver is accompanied by a rise in circulating HGF (33), sug-
gesting an endocrine mechanism of action. Expression of HGF 
by Kupffer cells has been observed in the context of liver repair 
and regeneration (34), and our in vitro data indicate that HGF 
also acts on parasitized hepatocytes to induce apoptosis. These 
observations are in line with a dual role of HGF in promoting 
either hepatocyte apoptosis or proliferation depending on the 
contextual cues (28, 34, 35). In fact, it was reported that HGF 
signaling in hepatoma cell lines favors sporozoite transition to 
the invasive mode and cell survival upon Plasmodium sporozoite 
infection, in a species-specific fashion (13, 14, 16). However, our 
data imply that HGF also has a role in controlling infection by 
inducing apoptosis of parasitized hepatocytes through a mecha-
nism that transcends Plasmodium species and does not require 
parasite traversing. Our results embody the hypothesis that HGF 
produced by infection-activated Kupffer cells, sensitizes primary 
hepatocytes to engage a mitochondrial-independent apoptosis 
program (Figures  2A–D) in parasitized cells with established 
EEFs (Figures 2E–H), potentially overcoming parasite strategies 
to block spontaneous apoptosis (9).
On the other hand, we observed that infected hepatocyte 
cultures exhibited spontaneous apoptosis, possibly explaining 
the reduction of infected cells number in the course of in vitro 
infection. In line with previous reports (10), we found that 
inhibition of Fas pathway significantly decreased apoptosis in 
infected cultures while increasing parasite yield, suggesting that 
susceptibility of infected hepatocytes to Fas-mediated apoptosis 
is an efficient way to control initial parasite liver stage infection. 
Coherently, stimulation of signaling through the Fas pathway 
decreased the number of infected hepatocytes that supported suc-
cessful infection. Intriguingly, FasL appears to be overproduced 
by non-infected hepatocytes that surround individual infected 
hepatocytes, suggesting that FasL-expressing cells provide a par-
acrine signal to induce apoptosis of the infected cells (Figure 4). 
Although susceptibility to Fas-mediated apoptosis plays a role 
in reducing parasite yield, this effect appeared to affect equally 
infected and non-infected hepatocytes in the infected cultures. 
In contrast, HGF signaling promotes a shift from mitochondrial-
dependent to mitochondrial-independent apoptosis (30) and 
preferentially targets infected cells in primary cultures. It remains 
to be investigated what are the intracellular requirements that 
license apoptosis by each of the two apoptosis mechanisms in 
order to disentangle their role in the time course of hepatocyte 
infection.
The decision of whether one infected hepatocyte undergoes 
apoptosis or support full parasite development might rely on 
time windows of host apoptosis induction, which is counteracted 
by effective parasite apoptosis-inhibiting activity (9). In fact, 
treatment with proapoptotic drugs in vivo was shown to delay or 
abrogate transition to blood stage infection (36). We have noted 
that the size of the EEFs found in TUNEL-positive cells in non-
sensitized cultures represent early forms of liver stage parasite, 
suggesting that spontaneous hepatocyte apoptosis is able to deter 
parasite development at early stages. In contrast, HGF treatment 
was capable of inducing apoptosis in hepatocytes containing EEFs 
of larger sizes, indicating that this apoptosis pathway is effective 
at later stages of parasite development. Together, these observa-
tions indicate that the fate of infected hepatocytes is dictated 
by paracrine interactions occurring between Kupffer cells and 
hepatocytes that direct hepatocyte apoptosis. Manipulation of 
such apoptosis mechanisms may provide an effective tool to block 
or suppress liver stage progression and confer disease protection.
The malaria liver stage infection is a current target for iden-
tification of protective responses based on the killing activity of 
parasite-specific CD8 T cells (37) operating independently of 
bone marrow-derived antigen-presenting cells (APCs) (38). The 
mechanisms of apoptosis of infected hepatocytes here described 
have potential impact in building up immunological memory 
against parasite epitopes presented by MHC class I molecules. 
On the one hand, phagocytosis of infected hepatocytes apoptotic 
bodies by professional APCs may represent an additional route 
to prime CD8 T cells specific for malaria liver stage epitopes (39). 
On the other hand, responses that increase apoptosis resistance of 
infected hepatocytes may provide an opportunity for enhancing 
antigen presentation in the liver, with consequent activation of 
liver-resident CD8 T cells that prevent transition to blood stage 
infection.
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